Oseltamivir and breastfeeding

International Journal of Infectious Diseases

Volumn 12, Issue 4, 2008, Pages 451-

  Wentges van Holthe, Netteke ^a   van Eijkeren, Marion ^a   van der Laan, Jan Willem ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; OSELTAMIVIR;

BREAST FEEDING; DRUG MILK LEVEL; DRUG SAFETY; HUMAN; INFLUENZA; INFLUENZA VIRUS A H5N1; LETTER;

ANTIVIRAL AGENTS; FEMALE; HUMANS; INFANT; MILK, HUMAN; OSELTAMIVIR;

EID: 44649130099     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2007.11.009     Document Type: Letter

References (4)

1. Murray C.J., Lopez A.D., Chin B., Feehan D., and Hill K.H. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 368 (2006) 2211-2218
2. Wiltshire H., Wiltshire B., Citron A., Clarke T., Serpe C., Gray D., et al. Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine. J Chromatogr B 745 (2000) 373-388
3. Tamiflu product monograph. F. Hoffmann-La Roche Ltd; 2006.
4. Schaefer C. Drugs during pregnancy and lactation. 1st ed. (2001), Elsevier, Amsterdam